| Taylor Quella, OTD, OTR/L | |
|
1725 S Naperville Rd Ste 110, Wheaton, IL 60189-5855 | |
| (815) 469-1500 | |
| Not Available |
| Full Name | Taylor Quella |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist - Pediatrics |
| Location | 1725 S Naperville Rd Ste 110, Wheaton, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073118196 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225XP0200X | Occupational Therapist - Pediatrics | 056013773 (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Taylor Quella, OTD, OTR/L 8 E 9th St Apt 1602, Chicago, IL 60605-4503 Ph: (574) 341-2383 | Taylor Quella, OTD, OTR/L 1725 S Naperville Rd Ste 110, Wheaton, IL 60189-5855 Ph: (815) 469-1500 |
News Archive
Four University of California, Davis, researchers have been given $50,000 each in the inaugural year of a competitive grant program aimed at facilitating the conversion of technology generated from university research into commercial applications.
Scientists in the U.S. say they have discovered a substance in the brain of mice that causes memory loss; they believe the discovery gives drug developers a target for creating drugs to treat memory loss in people with dementia.
Eisai Co.,Ltd. announced its latest research on evaluation about correlation of amyloid beta (Abeta) in plasma and in cerebrospinal fluid (CSF) by high precision measurement with the newly developed automated protein assay system, jointly developed with Sysmex Corporation, using full automated immunoassay system HISCLTM series for creating the simplified diagnosis of Alzheimer's disease with blood was presented at the Alzheimer's Association International Conference held in Los Angeles, California, United States, from July 14 to 18, 2019.
Allergan plc, a leading global pharmaceutical company, today announced that its wholly owned subsidiary has entered into an exclusive licensing agreement with Mimetogen Pharmaceuticals, a clinical stage biotechnology company, to develop and commercialize tavilermide (MIM-D3), a topical formulation of a novel small molecule TrkA agonist for the treatment of dry eye disease.
› Verified 9 days ago
Nancy Beck I, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 427 N West St, Wheaton, IL 60187 Phone: 630-853-2693 | |
Jaclyn A Berlino, MOT, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 26w171 Roosevelt Rd, Wheaton, IL 60187 Phone: 630-909-7150 | |
Beth E Bosak, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 26w171 Roosevelt Rd, Wheaton, IL 60187 Phone: 630-909-7150 | |
Maggie Henseler, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1725 S Naperville Rd Ste 110, Wheaton, IL 60189 Phone: 630-793-8404 Fax: 630-793-8401 | |
Deanna L Vasiliauskas, OT Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 150 E Willow Ave Ste 110, Wheaton, IL 60187 Phone: 630-967-2000 | |
Allyson Chrystal, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1725 S Naperville Rd Ste 110, Wheaton, IL 60189 Phone: 815-469-1500 |